Market Cap 105.54M
Revenue (ttm) 3.55M
Net Income (ttm) -14.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -419.15%
Debt to Equity Ratio 0.00
Volume 81,673
Avg Vol 98,106
Day's Range N/A - N/A
Shares Out 16.73M
Stochastic %K 8%
Beta 0.49
Analysts Strong Sell
Price Target $16.25

Latest News on COYA

Coya Therapeutics Now Pivots Toward Phase 2 In ALS And FTD

Feb 7, 2025, 5:17 PM EST - 7 weeks ago

Coya Therapeutics Now Pivots Toward Phase 2 In ALS And FTD


Coya Therapeutics: Buying The Dip After Unwarranted Sell-Off

Oct 31, 2024, 10:31 AM EDT - 5 months ago

Coya Therapeutics: Buying The Dip After Unwarranted Sell-Off


Coya Therapeutics Announces $10.0 Million Private Placement

Oct 22, 2024, 9:00 AM EDT - 5 months ago

Coya Therapeutics Announces $10.0 Million Private Placement


Coya Therapeutics to Present at Upcoming Healthcare Conferences

Sep 3, 2024, 8:15 AM EDT - 7 months ago

Coya Therapeutics to Present at Upcoming Healthcare Conferences


Coya Therapeutics to Participate in BTIG Fireside Discussion

Mar 12, 2024, 9:00 AM EDT - 1 year ago

Coya Therapeutics to Participate in BTIG Fireside Discussion